Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: 86-21-58550039;86-21-31268550-8004
Mobile:
Tel: 86-21-58550039;86-21-31268550-8004
Fax: 86-21-50790419
Province/state: shanghai
City: shanghai
Street: Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
MaxCard:
CAS NO.705260-08-8
Vorapaxar Sulfate global trader Reliable quality 705260-08-8 on hot selling
SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients.
Chemvon Biotechnology Co. Ltd is a high-technology pharmaceutical and fine chemical company, which is speciallized in RD, manufacturing and sales of APIs (Active Pharmaceutical Ingredients) and some organic intermediates.
With the experience and specialization in technology of asymmetric synthesis, total synthesis of natural products, organometallic reactions, chromatographic chiral separation, we supply high quality products of APIs, intermediates, speciality chemicals. and our contract services including research manufacture and custom synthesis from laboratory to commercial production are also offered on a confidential basis.
Chemvon puts great emphasis on product quality and service as followed in details:
Custom chemical services:
1. Contract custom manufacturing of intermediates and API's from microgrms up to multi tonnes scale;
2. Contract process research and upscaling studies;
3. Contract research in structure-activity of drug moleculars
Products:
1. Vitamins and steroids;
2. Organic intermediates, heterocyclic compounds including monomers of polymer materials and some building blocks;
3. Chiral synthons with multi-step reactions.
Welcome to you and your visit, let us make progress hand in hand!
Catalogue Number | V758200 |
Chemical Name | Vorapaxar Sulfate |
Synonyms | N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic Acid Ethyl Ester Sulfate;Sch 530348; |
CAS Number | 705260-08-8 |
Alternate CAS # | 618385-01-6-free base |
Molecular Formula | C??H??FN?O?S |
Appearance | White to Off-White Solid |
Melting Point | >199ºC (dec.) |
Molecular Weight | 590.66 |
Storage | Hygroscopic, Refrigerator, under inert atmosphere |
Solubility | Acetonitrile (Very Slightly, Heated), Methanol (Slightly) |
Category | Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
Applications | SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients. |
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package |